C. Negri
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Oncology top 10%
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
Papers in
-
- Cancer therapeutics and mechanisms 14
- Cell death mechanisms and regulation 6
- DNA and Nucleic Acid Chemistry 4
- Oncology 12
- PARP inhibition in cancer therapy 5
- Lung Cancer Research Studies 3
- Co-authors
- G. Ricotti (11 shared papers)A. Ivana Scovassi (15 shared papers)Rosa Bernardi (10 shared papers)Nicoletta Zini (3 shared papers)Maddalena Donzelli (10 shared papers)Ennio Prosperi (9 shared papers)Marco Bestagno (4 shared papers)Antonella Cerino (4 shared papers)
In The Last Decade
C. Negri
31 papers receiving 746 citations
Peers
Comparison fields: 5 of 81
- Toxicology 66
- Oncology 304
- Molecular Biology 563
- Immunology 100
- Rheumatology 46
Countries citing papers authored by C. Negri
This map shows the geographic impact of C. Negri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Negri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Negri more than expected).
Fields of papers citing papers by C. Negri
This network shows the impact of papers produced by C. Negri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Negri. The network helps show where C. Negri may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Negri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 95 | |
| 2 | 1992 | 90 | |
| 3 | 1994 | 56 | |
| 4 | 1997 | 47 | |
| 5 | 1999 | 46 | |
| 6 | 1999 | 43 | |
| 7 | 1993 | 37 | |
| 8 | 1993 | 35 | |
| 9 | Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. | 1989 | 31 |
| 10 | 1989 | 28 | |
| 11 | 1990 | 28 | |
| 12 | Topoisomerase II alpha and beta in human tumor cells grown in vitro and in vivo. | 1993 | 25 |
| 13 | 1990 | 23 | |
| 14 | Poly(ADP-ribose) synthesis in cells undergoing apoptosis: an attempt to face death before PARP degradation. | 1998 | 22 |
| 15 | 2003 | 22 | |
| 16 | 1997 | 20 | |
| 17 | 2001 | 20 | |
| 18 | 1994 | 19 | |
| 19 | 1993 | 15 | |
| 20 | 1995 | 12 |
About C. Negri
C. Negri is a scholar working on Molecular Biology, Oncology, Epidemiology, Organic Chemistry and Toxicology, having authored 31 papers that have together received 762 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Cell death mechanisms and regulation (6 papers), PARP inhibition in cancer therapy (5 papers), Synthesis and Biological Evaluation (4 papers), DNA and Nucleic Acid Chemistry (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Toxicology (66 citations), Oncology (304 citations), Molecular Biology (563 citations), Immunology (100 citations) and Rheumatology (46 citations). C. Negri has collaborated with scholars based in Italy, France and Germany. Frequent co-authors include G. Ricotti, A. Ivana Scovassi, Rosa Bernardi, Nicoletta Zini, Maddalena Donzelli, Ennio Prosperi, Marco Bestagno, Antonella Cerino, Spartaco Santi and Nadir M. Maraldi. Their work appears in journals such as Experimental Cell Research, Journal of Cellular Biochemistry, European Journal of Cancer, Carcinogenesis and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.